A detailed history of Concurrent Investment Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 1,847 shares of DXCM stock, worth $121,310. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,847
Previous 1,643 12.42%
Holding current value
$121,310
Previous $228 Million 8.11%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$110.31 - $140.45 $22,503 - $28,651
204 Added 12.42%
1,847 $209 Million
Q1 2024

May 07, 2024

SELL
$114.22 - $140.1 $35,065 - $43,010
-307 Reduced 15.74%
1,643 $228 Million
Q4 2023

Apr 15, 2024

BUY
$75.49 - $124.16 $147,205 - $242,112
1,950 New
1,950 $242 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.